The immuno-oncology therapy developer has launched with $56m in series A funding from investors including Taiho Ventures and UPMC enterprises.

Wearable health tracker developer Biovotion has been bought by digital therapeutics producer Biofourmis, enabling Swiss Re and STMicroelectronics to exit.

Ryan Miller has moved from a role overseeing corporate venturing and M&A at Anthem to a corporate development position at Change Healthcare.

The neurological disease therapy developer had raised about $57m from investors including Alphabet, Johnson & Johnson and Biogen.

Cancer data platform operator MedBanks raised the capital in a series D-plus round led by Tencent, also a contributor to its series D in January.

Home diagnostics test provider Healthians collected $11.8m from investors including two Digital Garage vehicles to help broaden its technology, services and geographical presence.

Corporate venturing unit Johnson & Johnson Innovation – JJDC has appointed Chris Picariello president following the retirement of Tom Heyman.

UAVenture Capital Fund II has backed University of Arizona spinout StimAire, which is working on neuromodulation-based treatments for conditions including obstructive sleep apnoea.

Toppan Printing, Mitsui Sumitomo Insurance, Elan Corporation and CBC Co all invested in a $15.6m round for medical suppliers e-commerce platform Medikabazaar.

Smoking cessation service Carrot has hired Busy Burr as president and CEO, months after she left Humana after setting up its corporate venturing arm.